BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11431748)

  • 21. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
    Miller DS; Kotlarski I; Jilbert AR
    Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus.
    Lenhoff RJ; Luscombe CA; Summers J
    Hepatology; 1999 Feb; 29(2):563-71. PubMed ID: 9918936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGF induces cell cycle arrest of A431 human epidermoid carcinoma cells.
    MacLeod CL; Luk A; Castagnola J; Cronin M; Mendelsohn J
    J Cell Physiol; 1986 Apr; 127(1):175-82. PubMed ID: 3007537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway.
    Wu TT; Coates L; Aldrich CE; Summers J; Mason WS
    Virology; 1990 Mar; 175(1):255-61. PubMed ID: 2155510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B Virus Covalently Closed Circular DNA Formation in Immortalized Mouse Hepatocytes Associated with Nucleocapsid Destabilization.
    Cui X; Guo JT; Hu J
    J Virol; 2015 Sep; 89(17):9021-8. PubMed ID: 26085156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of hepatocyte growth factor on the growth and metabolism of human hepatocytes in primary culture.
    Gómez-Lechón MJ; Castelli J; Guillén I; O'Connor E; Nakamura T; Fabra R; Trullenque R
    Hepatology; 1995 May; 21(5):1248-54. PubMed ID: 7737630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dynamics of HBV covalently closed circular DNA: amplification and clearance].
    Zhao KK; Miao QL; Miao XH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):794-6. PubMed ID: 19874702
    [No Abstract]   [Full Text] [Related]  

  • 28. Simian virus 40 induces multiple S phases with the majority of viral DNA replication in the G2 and second S phase in CV-1 cells.
    Lehman JM; Laffin J; Friedrich TD
    Exp Cell Res; 2000 Jul; 258(1):215-22. PubMed ID: 10912803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte growth factor activates CCAAT enhancer binding protein and cell replication via PI3-kinase pathway.
    Cho MK; Kim SG
    Hepatology; 2003 Mar; 37(3):686-95. PubMed ID: 12601366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis.
    Drucker C; Parzefall W; Teufelhofer O; Grusch M; Ellinger A; Schulte-Hermann R; Grasl-Kraupp B
    Carcinogenesis; 2006 Jan; 27(1):152-61. PubMed ID: 16081514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells.
    Tuttleman JS; Pourcel C; Summers J
    Cell; 1986 Nov; 47(3):451-60. PubMed ID: 3768961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
    Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
    Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor (TNF) receptor-2-mediated DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: The involvement of endogenous transforming growth factor-alpha.
    Okamoto H; Kimura M; Watanabe N; Ogihara M
    Eur J Pharmacol; 2009 Feb; 604(1-3):12-9. PubMed ID: 19100731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth and differentiation factors inhibit the migratory phenotype of cultured neonatal rat hepatocytes induced by HGF/SF.
    Pagan R; Martín I; Llobera M; Vilaró S
    Exp Cell Res; 1997 Aug; 235(1):170-9. PubMed ID: 9281366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of in vitro growth potential of hepatocytes expressing hepatocyte growth factor in an autocrine fashion.
    Shiota G; Kawasaki H; Nakamura T; Schmidt EV
    Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):151-6. PubMed ID: 7994559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation of DHBV pre-S: identification of the major site of phosphorylation and effects of mutations on the virus life cycle.
    Borel C; Sunyach C; Hantz O; Trepo C; Kay A
    Virology; 1998 Mar; 242(1):90-8. PubMed ID: 9501048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human bone marrow mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vivo and in vitro.
    Xie C; Zheng YB; Zhu HP; Peng L; Gao ZL
    Cell Biol Int; 2009 Apr; 33(4):493-500. PubMed ID: 19272332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
    Huang YQ; Wang LW; Yan SN; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor beta 1 inhibits mouse keratinocytes late in G1 independent of effects on gene transcription.
    Alexandrow MG; Moses HL
    Cancer Res; 1995 Sep; 55(17):3928-32. PubMed ID: 7641212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
    Miller DS; Halpern M; Kotlarski I; Jilbert AR
    Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.